Healthcare >> Sector Roundtables >> September 21, 1998
ROBERT H. UHL is a Vice President in Salomon Smith Barney's equity
research department where he covers the specialty pharmaceutical/drug
delivery sector. Previously, he was associated with F. Eberstadt. He
earned his Bachelor's degree in microbiology from Purdue University
after which he conducted pharmacology research with the equity research
facility at the University of Kentucky. Mr. Uhl received his Master's
degree in International Business from the University of South Carolina. Profile
RICHARD B. SILVER is a Senior Vice President and Senior Research Analyst
at Lehman Brothers, where he is a member of the healthcare equity
research team. Mr. Silver focuses on specialty and niche
pharmaceuticals, drug delivery technology and generic drugs. Prior to
joining Lehman Brothers he was with Chase Manhattan Bank as a Credit
Analyst. Mr. Silver hold a BA from the University of Connecticut. Profile
IAN C. SANDERSON is a Managing Director at SG Cowen. A member of the
Healthcare/ Pharmaceutical Team, he covers emerging and mid cap
pharmaceutical companies including specialty pharmaceutical, drug
delivery and generic pharmaceutical companies. Prior to joining SG
Cowen, Mr. Sanderson was associated with Houlihan Lokey Howard & Zukin,
Cambridge Associates and Putnam International Advisors and U.S. Surgical
Corporation. He received a BA in Political Economy from Williams College
and an MBA in Finance from the Wharton School at the University of
Pennsylvania. Profile
ALEX ZISSON is a Managing Director and Senior Pharmaceutical Analyst
with Chase H&Q. He earned his Bachelor's degree from Brown University.
In his leisure, Mr. Zisson enjoys 'thinking about ways to make his
clients money' and playing bridge. Profile
Do you expect to see an increasingly large percentage of the health care
dollar being spent on pharmaceuticals as the
